cilomilast has been researched along with oxadiazoles in 2 studies
| Studies (cilomilast) | Trials (cilomilast) | Recent Studies (post-2010) (cilomilast) | Studies (oxadiazoles) | Trials (oxadiazoles) | Recent Studies (post-2010) (oxadiazoles) |
|---|---|---|---|---|---|
| 162 | 13 | 42 | 6,057 | 257 | 2,359 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hersperger, R; Mazzoni, L; Trifilieff, A; Walker, C; Wyss, D | 1 |
| Beebe, DJ; Bushman, W; Domenech, M; Frantskevich, K; Hammer, KD; Malinowski, RL; Marker, PC; Powers, GL | 1 |
2 other study(ies) available for cilomilast and oxadiazoles
| Article | Year |
|---|---|
Pharmacological profile of a novel phosphodiesterase 4 inhibitor, 4-(8-benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic acid (NVP-ABE171), a 1,7-naphthyridine derivative, with anti-inflammatory activities.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchoalveolar Lavage Fluid; Caco-2 Cells; Cell Division; Cell Membrane Permeability; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Humans; Isoenzymes; Mice; Mice, Inbred BALB C; Naphthyridines; Neutrophils; Nitriles; Oxadiazoles; Phosphodiesterase Inhibitors; Pneumonia; Rats; Rats, Inbred BN; Respiratory Burst; Tumor Necrosis Factor-alpha | 2002 |
Phosphodiesterase 4D inhibitors limit prostate cancer growth potential.
Topics: Animals; Cell Proliferation; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Hedgehog Proteins; Humans; Male; Mice; Mitogen-Activated Protein Kinase Kinases; Naphthyridines; Nitriles; Oxadiazoles; Phosphodiesterase 4 Inhibitors; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction; Xenograft Model Antitumor Assays | 2015 |